Healio Nov 28, 2023
Long-term use of the potassium binder patiromer may improve clinical outcomes among patients with chronic kidney disease and hyperkalemia according to a study.ampldquoWhile patiromer use among patients with advanced CKD has been shown to reduce the discontinuation of renin-angiotensin-aldosterone system inhibition therapy it remains unclear whether patiromer can improve clinical